key: cord-0876025-digit6p3
authors: Bello-Chavolla, O. Y.; Antonio-Villa, N. E.; Fernandez-Chirino, L.; C. Guerra, E.; Fermin-Martinez, C. A.; Marquez-Salinas, A.; Vargas-Vazquez, A.; Bahena-Lopez, J. P.
title: Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data
date: 2021-01-04
journal: nan
DOI: 10.1101/2021.01.02.21249141
sha: 5cf5107c5d00f8afa283b266e173ab6ad90e3a73
doc_id: 876025
cord_uid: digit6p3

BACKGROUND: SARS-CoV-2 testing capacity is important to monitor epidemic dynamics. Given difficulties of large-scale RT-PCR implementation, rapid antigen tests (Rapid Ag-T) have been proposed as alternatives in settings such as Mexico. OBJECTIVES: To evaluate diagnostic performance of Rapid Ag-T for SARS-CoV-2 infection and its associated clinical implications compared to RT-PCR testing in Mexico. METHODS: We analyzed data from the COVID-19 registry of the Mexican General Directorate of Epidemiology up to December 31st, 2020 (n=3,374,165) and cases with both RT-PCR and Rapid Ag-T (n=18,446). We evaluated diagnostic performance using accuracy measures and assessed time-dependent changes in AUROC. We also explored test discordances as predictors of hospitalization, intubation, severe COVID-19 and mortality. RESULTS: Rapid Ag-T is primarily used in Mexico City. Rapid Ag-T have low sensitivity 37.6% (95%CI 36.6-38.7), high specificity 95.4% (95%CI 95.1-95.8) and acceptable positive 86.1% (95%CI 85.0-86.6) and negative predictive values 67.2% (95%CI 66.2-69.2). Rapid Ag-T has optimal diagnostic performance up to days 7-10 after symptom, and its performance is modified by testing location, comorbidity, and age. RT-PCR(-) / Rapid Ag-T(+) cases had higher risk of adverse COVID-19 outcomes and were older, RT-PCR(+)/ Rapid Ag-T(-) cases had slightly higher risk or adverse outcomes and [≥]7 days from symptom onset. Cases detected with rapid Ag-T were younger, without comorbidities, and milder COVID-19 course. CONCLUSIONS: Rapid Ag-T could be used as an alternative to RT-PCR for large scale SARS-CoV-2 testing in Mexico. Interpretation of Rapid Ag-T results should be done with caution to minimize the risk associated with false negative results.

SARS-CoV-2 testing capacity has been regarded as a fundamental factor to achieve pandemic control around the world 1 . It has been proposed that prompt isolation of possibly contagious individuals identified by testing and contact tracing is one of the most effective measures to reduce community-level transmission of SARS-CoV-2 infection; furthermore, effective reduction of community-level transmission can only be achieved with well-designed, universal, and cost-effective testing strategies 2 . Although reverse transcription polymerase chain reaction tests (RT-PCR) have been the reference for detection of active SARS-CoV-2 infections, its systematic implementation entails significant technical difficulties in limited resource settings 3 .

In order to address these methodological issues, the World Health Organization (WHO) proposed that rapid antigen tests (Rapid Ag-T) and other point-of-care tests (POCTs), which have demonstrated to have a high specificity compared to other molecular techniques 4 In Mexico, local authorities implemented a sentinel system-testing policy focused on tracking severe cases of COVID-19, and to a lesser extent those mild to moderate cases. Nevertheless, it has been reported that the implementation of full contact tracing procedure is only performed in areas where RT-PCR testing facilities are available 9 . Rapid Ag-T have been recently promoted as a dynamic strategy for detection of active SARS-CoV-2 infection in Mexico to address these issues; however, despite being recommended by the WHO and used worldwide, few studies have evaluated their performance using large epidemiological real-world data 6, 7 .

The increased use for Rapid Ag-T in Mexico demands a comprehensive evaluation for its diagnostic performance when compared to current reference testing techniques. Furthermore, its clinical implications could lead to the identification of subjects at risk for discrepancies of . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint utilized, whereby 475 health facilities which comprise a nationally representative sample evaluate ~10% of mild outpatient cases to provide estimates of confirmed mild cases 9, 12 .

After October 28 th , 2020, tests for SARS-CoV-2 infections additionally included those who were detected using one of the three available Rapid Ag-T including STANDARD™Q COVID-19 Ag Test, Panbio™ COVID-19 Ag RAPID Test Device, and Sofia2 SARS Antigen FIA by Quidel Corporation, which are approved by use and evaluated for efficacy by the National Institute for Epidemiological Diagnosis and Reference and the WHO 13 . These Rapid Ag-T are available in healthcare community-level locations for testing access of suspected COVID-19 cases or by epidemiological association with a suspected case and currently used for tracking the epidemic in Mexico City 14 . Confirmed SARS-CoV-2 infection is defined as an individual with a positive Rapid Ag-T or a positive RT-PCR test; all negative Rapid Ag-T with suspected epidemiological association with a confirmed SARS-CoV-2 case or a clinical profile with high suspicion of COVID-19 are eligible for further evaluation with RT-PCR testing within testing facilities 9 .

For cases who had both RT-PCR and rapid antigen test information available, we used the RT-PCR result as a reference test to classify cases as true positive (RT-PCR + / Rapid Ag-T +), true negative (RT-PCR -/ Rapid Ag-T -), false positive (RT-PCR -/ Rapid Ag-T +) and false negative (RT-PCR + / Rapid Ag-T -). Severe outcomes were defined as a composite of either death, ICU admission or requirement for invasive ventilation; hospital admission, requirement for invasive intubation and lethality were also evaluated as outcomes. Follow-up time was estimated in days from symptom onset until either hospitalization or death, depending on the outcome of interest, or censoring up to last known follow-up, whichever occurred first.

We compared testing rates standardized per 100,000 inhabitants across Mexican municipalities and its trends over time after its implementation in late October comparing testing . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint rates between Mexico City and the rest of Mexico due to the high density of Rapid Ag-T in the first. We also compared incident cases detected with RT-PCR and Rapid Ag-T in Mexico City compared to the rest of the country. Furthermore, we compared cases who were assessed exclusively with Rapid Ag-T, RT-PCR, or both to identify factors which influence testing in these settings.

We evaluated the performance of Rapid Ag-T compared to RT-PCR using complete-case analysis of individuals who had both results available using confusion matrices and areas under the receiving operating characteristic curves (AUROC) with the caret and pROC R packages.

We further estimated sensitivity, specificity, positive and negative predictive values (PPV, NPV, respectively) and positive and negative likelihood ratios (LR+ and LR-, respectively) and its corresponding 95% confidence intervals with DeLong's method with the OptimalCutpoints R package. To evaluate the performance of Rapid Ag-T in different settings, we stratified these metrics according to testing location (Mexico City vs. Rest of Mexico), patient status (inpatient vs. outpatient), cases with and without comorbidities, age (>60 vs. ≤60 years) and time from symptom onset to evaluation (>7 vs ≤7 days from onset).

We evaluated time-varying diagnostic performance or Rapid Ag-T using time-dependent ROC curves with the timeROC R package with inverse probability weighting in Cox regression, adjusted for age and sex for 1, 3, 5, 7, 10 and 15 days from symptom onset. We further evaluated the performance of Rapid Ag-T to predict hospitalization, mortality, and intubation, in cases with or without added RT-PCR testing using the same proposed cut-offs.

We tested for predictors of Rapid Ag-T and RT-PCR discrepancies using mixed effects logistic regression, considering heterogeneity in epidemic dynamics across Mexico including municipality of residence as a random effect. To dissect predictors of test discrepancy, for false . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint positive models we included only false positive and true negative cases and for false negative models we included true positive and false negative cases. We adjusted all models for age, sex, time from symptom onset and comorbidities.

First, we evaluated predictors for hospitalization, lethality and the composite event of severe outcomes using time-to-event models under the proportional risk assumption with mixedeffects Cox regression incorporating municipality of residence as a random effect within the frailty term to control for geographical heterogeneity. Next, we evaluated the risk associated with true or false positives and false negatives in Rapid Ag-T compared to true negatives using RT-PCR for hospitalization, lethality and severe outcomes using mixed effects Cox regression models, adjusted for covariates. Both for outcome predictors and for the implication of test discordances on intubation rates, we fitted mixed effects logistic regression models adjusted for covariates and considering municipality of residence as a random effect. For Cox models, proportional risk assumptions were verified using Schönfeld residuals and visual inspection of time-varying effects; for logistic regression models, goodness of fit was evaluated using the Hosmer-Lemeshow test and model selection was carried out using minimization of the Bayesian Information Criterion (BIC). All statistical analyses were conducted using R language version 4.0.3 and a p-value <0.05 was considered as the statistical significance threshold.

Until December 31 st , 2020 a total of 3,374,165 subjects had been tested for SARS-CoV-2 in Mexico. Amongst them, 3,009,578 had only an RT-PCR test, 340,484 had only a rapid antigen test and 24,103 subjects had both RT-PCR and rapid antigen tests. When comparing characteristics amongst the three previous groups, cases tested using Rapid Ag-T were younger, predominantly female, had lower rates of chronic comorbidities, and fewer cases who presented with features of severe COVID-19 including pneumonia, requirement for ICU . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint admission, intubation, or death. Notably, cases who undertook Rapid Ag-T had lower median days from symptom onset to clinical assessment ( Table 1) .

Amongst tested cases, a total of 1,369,368 (40.6%) cases had confirmed SARS-CoV-2 infection using either of those tests and 2,004,797 (59.4%) had a negative result. The rate of positivity was lower for Rapid Ag-T compared to RT-PCR. After the implementation of Rapid Ag-T, the rate of testing using this method was the largest in Mexico City, with over 3,849.55 tests per 100,000 habitants, marginally followed by the state of Tabasco with 181.71 Rapid Ag-T per 100,000 habitants. As of December 31 st , 2020, ~80% of SARS-CoV-2 testing in Mexico City is being carried out using Rapid Ag-T compared with <10% in the rest of Mexico. Overall, amongst 94,029 confirmed SARS-CoV-2 cases using Rapid Ag-T, 74,178 (78.9%) were confirmed in Mexico City (Figure 1) . A STARD diagram depicting all evaluated cases and a histogram of time from onset to testing is presented in Supplementary Material. These cases had higher rates of chronic comorbidities and COVID-19 complications compared to cases with Rapid Ag-T only, but lower rates compared to RT-PCR only ( Table 1) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint outpatients, younger cases without comorbidities and, notably, in cases who had ≥7 days from symptom onset at evaluation.

Given the aforementioned observation of time-varying performance according to the time from symptom onset, we used time-dependent ROC curves to model changes in diagnostic performance over time for detection of SARS-CoV-2 infection. We observed that, compared to RT-PCR, Rapid Ag-T had the better AUROC at 7 days and its performance subsequently decreased until reaching the lowest AUROC at 15 days after symptom onset, adjusted for age and sex. Next, we evaluated whether using one test modality provided better predictive capacity for hospitalization, intubation and mortality, which would have relevant clinical implications for test selection. We observed that a positive RT-PCR was best at predicting hospital admission between 7-10 days after symptom onset and mortality at days 10-15, without significant utility for intubation. For Rapid Ag-T, we observed similar trends, with an optimal window for mortality between days 7-10 after symptom onset ( Table 3) .

We evaluated predictors of false positive and negative results in Rapid Ag-T for SARS-CoV-2 using RT-PCR as reference test. Cases with false negative results had ≥7 days from symptom onset, were younger, and predominantly female. Regarding comorbidities, cases with false negative results were less likely to have underlying immunosuppression, obesity and chronic kidney disease. Regarding false positive results, we only observed increasing age as a significant predictor, with a non-significant trend in cases with chronic kidney disease ( Figure   2 ). Next, we investigated whether these test discordances were predictive of COVID-19

outcomes. Regarding hospitalization we observed that, compared to true negative results, risk for hospitalization was higher for cases with false positive (HR 1.79, 95%CI 1.43-2.24), false negative (HR 1.16, 95%CI 1.04-1.29) and true positive (HR 1.89, 95%CI 1.69-2.12) Rapid Ag-T results, adjusted for treatment setting, comorbidities, sex and age. Compared to true negative . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. Figure 3) . 12, 15 . We observed that age, comorbidity and time from symptom . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint onset significantly impact the performance of Rapid Ag-T for SARS-CoV-2 and that optimal performance for these tests decreases after 7-10 days from symptom onset. Furthermore, we identified that positive Rapid Ag-T in cases with negative RT-PCR have higher risks for severe COVID-19 outcomes, indicating potential benefit for the use of Rapid Ag-T in addition to RT-PCR testing; notably, cases with false negative results in Rapid Ag-T have slightly higher risk of severe COVID-19 outcomes, with the main determinant for false negative status being the time from symptom onset to test assessment. Finally, older patients with negative RT-PCR had higher odds of a positive Rapid Ag-T, which might call for implementation of sequential testing using Rapid Ag-T after a negative RT-PCR in older adults with high clinical suspicion. Our results represent the largest evaluation on the usefulness of Rapid Ag-T in a real-world setting as well as on how some common chronic conditions might modify its accuracy in comparison with RT-PCR tests. With the recent but limited availability of vaccines to prevent symptomatic SARS-CoV-2, consistent prevention of community-level transmission remains paramount to reduce contagions and prevent mortality until an ideal vaccination threshold can be achieved 16 .

In this setting, widespread, frequent and repeated use of Rapid Ag-T is preferable given the limited implementation of large-scale RT-PCR testing for SARS-CoV-2 in Mexico 4,17 .

The use of POCTs is relevant in pandemic settings, where test results can be used to promote self-isolation, adequate treatment allocation and to further contact tracing to reduce rapid dissemination of SARS-CoV-2 18 . A recent meta-analysis of rapid POCTs for SARS-CoV-2 infection evaluated the use of Rapid Ag-T in different settings, identifying varying values of sensitivity coupled with high specificity, accordingly with our study 19 . The authors concluded that Rapid Ag-T can be used as a triage to allocate RT-PCR testing in limited resource settings, which is compatible with our assessment of the clinical implications of false negatives using Rapid Ag-T to detect SARS-CoV-2 infection 20 . Our results show that Rapid Ag-T yield a low sensitivity but a very high specificity for detection of SARS-CoV-2 when compared to RT-PCR.

Despite the low sensitivity, the positive and negative predictive values are high likely due to the . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint high prevalence of SARS-CoV-2 in the community 19 . This is consistent with reports of a reanalysis of published data of diagnostic accuracy of RT-PCR SARS-CoV-2 testing, which described that the risk of false positives increases when extending testing strategies, with increased in false negatives being attributable to local outbreaks 21 . In our study, Rapid Ag-T in Mexico City had a higher LR+ compared with the rest of the country, with equally high rates of false negative results using rapid antigen testing; notably, this testing modality is being used in this location to track trends of the COVID-19 pandemic. Special caution should be taken when evaluating and communicating negative results of rapid antigen tests for SARS-CoV-2, which if misinterpreted could be misleading and reduce adherence for self-isolation of asymptomatic cases identified via contact tracing 22 .

Prior to the instauration of widespread Rapid Ag-T, the Mexican Ministry of Health selected cases for RT-PCR testing based on a sentinel-surveillance system which identified cases based on the presence of respiratory symptoms, leading to an overrepresentation of severe and critical COVID-19 cases 9 . Our group previously profiled cases with non-respiratory symptoms and asymptomatic SARS-CoV-2 infections in Mexico City; we identified that no single symptom offered a reliable assessment of disease severity at the time of initial evaluation, even in population at high risk of contagion such as healthcare workers, as has been confirmed by a recent meta-analysis 23-25 . Given recent evidence which highlights the potential of pre-symptomatic and asymptomatic SARS-CoV-2 transmission and the usefulness of contact tracing as a complement to social distancing and community mitigation policies, SARS-CoV-2 testing should be extended to cases with recent contact with known COVID-19 cases despite the absence of symptoms 22,26,27 . Unfortunately, POCTs have relevant limitations on its diagnostic performance which may question its widespread use to inform public policy or for clinical decision making. Particularly, Rapid Ag-T require an active and symptomatic infection and sampling must be done no later than 7 days after beginning of symptoms, while RT-PCR can be used to assess asymptomatic cases and requires less amount of sample to . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint yield a positive result 28 . Our data similarly suggests that the time-varying diagnostic performance or Rapid Ag-T might have similar shortcomings to those observed in RT-PCR testing and which need to be considered when using the result of either method to inform decision-making 29, 30 . Future studies should investigate the utility of Rapid Ag-T as triage for RT-PCR use in asymptomatic SARS-CoV-2 infection as well as the ideal time frames to reduce the likelihood of discordant results when implementing sequential testing.

Our study had some strengths and limitations. We are using a large national registry of COVID-19 cases, many of whom were tested using both Rapid Ag-T and RT-PCR in a real-world setting which allowed us to reasonably assess diagnostic performance of Rapid Ag-T to detect SARS-CoV-2 infection. We were also able to assess the clinical impact of discordant results on COVID-19 outcomes as well as predictors which indicate settings where additional testing might be useful to reduce the externalities associated with false negative results. Regarding the limitations to be acknowledged is the potential influence of a spectrum effect, where diagnostic accuracy measures vary according to COVID-19 prevalence and the potential detection bias of only testing most cases once, likely missing infections who were initially categorized as false negative with RT-PCR early in the course of infection 31,32 . Furthermore, the use of the sentinel surveillance system to detect and report COVID-19 cases in Mexico likely skews detection towards more severe cases who may also have longer time from symptom onset to evaluation, increasing time-dependent heterogeneity within estimation of predictive accuracy measures 29 . Finally, the lack of disaggregated symptom data prevents assessment of the influence of various symptom clusters in modifying disease detection with different testing modalities, which remains as an area of opportunity for future research 33 .

In conclusion, Rapid Ag-T could be a useful strategy to extend SARS-CoV-2 screening and track trends of the COVID-19 pandemic in Mexico. Rapid Ag-T have poor sensitivity with high specificity but in a setting of local outbreaks, these tests might have high predictive values and be a helpful complement to contact tracing if properly implemented. Rapid Ag-T should be . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint performed widely and frequently to increase the usefulness of low-sensitive tests and increase diagnostic accuracy as well as to guide allocation of RT-PCR testing in low-resource settings 4, 19, 34 

All data sources and R code are available for reproducibility of results at https://github.com/oyaxbell/covid_antigen_mx. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. Table 3 . Time-dependent area under ROC curves using inverse weighted probability with Cox regression for detection of SARS-CoV-2 infection, adjusted for age assessing the performance of rapid antigen tests compared to RT-PCR at days 1, 3, 7, 10 and 15. The table also shows the ability of RT-PCR or rapid antigen tests to predict hospitalization, intubation and mortality related to COVID-19 at . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2021.01.02.21249141 doi: medRxiv preprint

Tracking COVID-19: Contact Tracing in the Digital Age

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

Optimising SARS-CoV-2 pooled testing for lowresource settings

COVID-19 testing: One size does not fit all

Real-life validation of the Panbio TM France threatens epidemic control

Lineamiento Estandarizado para la Vigilancia Epidemiológica y por

Laboratorio de la enfermedad respiratoria viral. gob.mx

Datos Abiertos Dirección General de Epidemiología. gob.mx

Updating standards for reporting diagnostic accuracy: the development of STARD

Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico

Listado de pruebas de antígeno para SARS CoV 2. gob.mx. Accessed

COVID-19. Pruebas rápidas COVID-19 se aplican en 200 quioscos, macro quioscos y centros de salud. COVID-19

Unequal Impact of prioritization strategies by age and serostatus. medRxiv

Rethinking Covid-19 Test Sensitivity -A Strategy for Containment

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Rapid, point-of-care antigen and molecularbased tests for diagnosis of SARS-CoV-2 infection

Rapid antigen and molecular tests had varied sensitivity and ≥97%

specificity for detecting SARS-CoV-2 infection

Estimation of the diagnostic Male sex (%) 1,453,173 (48.3)

Confirmed SARS-CoV-2 (%) 1

FUNDING: No funding was received.

Nothing to disclose.